Harvard Bioscience: Tools to Advance Life Science Research and Regenerative Medicine
 
Click on these icons to download or listen to our latest investor information:  


Investor Relations
 
Investor Presentation
Annual Report
Latest Live Presentation
Earnings Call
Print Page
Email Page
 
Our History Our Mission Financial Performance Business Model
Directions to Harvard Bioscience Investor Contact About Harvard Bioscience

Insider Transactions


Date Name Title Type Shares Traded Price Range
Feb 19, 2013 Lewis, Earl R. Director Option Execute 27,500 3.72
Jan 14, 2013 luscinski susan m Officer Disposition (Non Open Market) 11,475 4.38
Dec 21, 2012 Green, David Officer Sell 14,409 4.06
Dec 21, 2012 Green, David Officer Option Execute 14,409 3.16
Dec 20, 2012 Green, David Officer Sell 73,591 4.05
Dec 20, 2012 Green, David Officer Option Execute 73,591 3.16
Dec 19, 2012 Green, David Officer Sell 48,146 4.04
Dec 19, 2012 Green, David Officer Option Execute 48,146 3.16
Dec 18, 2012 Green, David Officer Sell 14,300 4.08
Dec 18, 2012 Green, David Officer Option Execute 45,946 3.16
Dec 17, 2012 Green, David Officer Sell 17,908 4.10
Dec 17, 2012 Green, David Officer Option Execute 17,908 3.16
Dec 11, 2012 graziano chane Officer Option Execute 200,000 3.48
Dec 11, 2012 luscinski susan m Officer Option Execute 100,000 3.16
Jun 1, 2012 dishman robert a Director Acquisition (Non Open Market) 8,403 n/a
Jun 1, 2012 graziano chane Officer Acquisition (Non Open Market) 105,042 n/a
Jun 1, 2012 Green, David Officer Acquisition (Non Open Market) 88,737 n/a
Jun 1, 2012 harte neal j Director Acquisition (Non Open Market) 8,403 n/a
Jun 1, 2012 kennedy john f Director Acquisition (Non Open Market) 8,403 n/a
Jun 1, 2012 Lewis, Earl R. Director Acquisition (Non Open Market) 8,403 n/a
Showing 1-20 of 123 transactions Page: 1 2 3 4 5 6 7  See Next 20

Stock transaction information provided by EDGAR Online. Harvard Bioscience, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.



Disclaimer:
The information contained within this and other Harvard Bioscience Web pages should be deemed accurate and current as of the date of the most recent update, or if no update information has been provided, the date of issuance. Harvard Bioscience assumes no responsibility for any misincurrances or misstatements which occur as the result of the reading of dated material. Users are strongly encouraged to check dates of issuance and most recent update of any information contained within, or linked to, Harvard Bioscience’s web site. For Harvard Bioscience’s most current information please reference Harvard Bioscience public filings with the Securities and Exchange Commission located at http://www.sec.gov.


Privacy Policy   |   Terms and Conditions
Copyright©2013 Harvard Bioscience, Inc. All rights reserved.
1-800-272-2775   1-508-893-8999